최제용 교수(의과대학 의학과)
o (1988) B.S., Kyungpook National University(KNU), Dentistry, Daegu, South Korea
o (1990) M.A., Kyungpook National University, Biochemistry
o (1994) Ph.D., Kyungpook National University, Biochemistry
o (2021~present) Professor, Department of Biochemistry & Cell Biology, School of Medicine, KNU, Daegu, Korea
o (2018~2021) Advisory board member, Science and Technology Policy Institute (STEPI), Korea
o (2017~2018) Director, Industry and Academic Cooperation Foundation, KNU, Korea
o (2019~present) Director, Laboratory Animal Resources in KNU, Daegu, Korea
o (2008~2009) Visiting Professor, Graduate School of Medicine, University of Tokyo, Japan
o (2019~present) Director, Laboratory Animal Resources in KNU, Korea
o (1998~1999) Instructor, Massachusetts Medical School, USA
o (1996~1998) Postdoctoral Researcher, Massachusetts Medical School, USA
Osteoarthritis,
Osteoporosis,
Vascular Calcification,
Bone Cell Biology,
Biomineralization,
Runx/Cbfb transcription factors,
Mouse genetics
o Essential roles for Cbfb in osteoblast formation and chondrocyte maturation by Runx2 and in articular chondrocyte maintenance by Runx1.
o Various biological applications of 4-Hexylresorcinol, including anticancer, anti-inflammatory, and biocompatibility enhancing functions.
o Establishment of a mouse vascular calcification (VC) model using high dose vitamin D and identifying the essential role of Runx2 and VDR in VC.
o Essential role of the Runx2 carboxyl terminus for subnuclear targeting, osteoblast formation, and chondrocyte maturation during skeletal tissue development
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):